Most drug side effects not due to error, study says

June 2007
Healthcare Risk Management;Jun2007, Vol. 29 Issue 6, p69
The article reports on the results of a study on the causes of drug side effects at U.S. hospitals conducted by the Agency for Healthcare Research and Quality.


Related Articles

  • DO NOT CRUSH OR CHEW.  // Monthly Prescribing Reference;Jan2011, Vol. 27 Issue 1, p57 

    The article offers information on various medications and drugs that should not be chewed or crushed inside the mouth including Zonegran, Caplet, and Avodart.

  • benzydamine hydrochloride.  // Royal Society of Medicine: Medicines;2002, p108 

    The article presents information on benzydamine hydrochloride, a drug which has counter-irritant or rubeacient action and can be used for the symptomatic relief of pain when applied to the skin, mouth ulcers and other sores or inflammation in the mouth and throat. Its adminstration is by topical...

  • Clonazepam (Rivotril) oral drops. Ramadaniati, Hesty U. // Journal of Pharmacy Practice & Research;Jun2015, Vol. 45 Issue 2, p243 

    A response from the author of the article "Snapshot Versus Continuous Documentation of Pharmacists' Interventions: Are Snapshots Worthwhile?" in a 2014 issue concerning the Rivotril or clonazepam oral drops is presented.

  • Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases. Ho, Stephen W-C; Beilin, Lawrence J. // British Medical Journal (Clinical Research Edition);9/24/1983, Vol. 287 Issue 6396, p876 

    Presents a case report of asthma associated with N-acetylcysteine infusion and paracetamol poisoning. Clinical features of the patients; Causes of morbidity and mortality; Issues of intravenous administration of N-acetylcysteine.

  • Once-Weekly Fluoxetine. Wagstaff, A.J.; Goa, K.L. // Drugs;Dec2001, Vol. 61 Issue 15, p2221 

    â–´ The relatively long half-life of the selective serotonin reuptake inhibitor fluoxetine has allowed the development of a delayed-release (enteric-coated) formulation containing 90mg fluoxetine per capsule for once-weekly oral administration. â–´ The cumulative relapse rate in patients...

  • Amiodarone.  // Reactions Weekly;9/8/2007, Issue 1168, p5 

    The article describes the cases of elderly patients, previous smokers, who developed pneumonitis during the administration of amiodarone. The man who was diagnosed with paroxysmal atrial fibrillation switched from amiodarone to IV methylprednisolone after a restrictive ventilatory defect and...

  • Pegvisomant.  // Reactions Weekly;8/23/2008, Issue 1216, p28 

    The article describes the case of a 33-year-old woman with acromegaly who developed subcutaneous lipoatrophy with subsequent impairment of drug absorption and effectiveness during treatment with pegvisomant. She started receiving pegvisomant in combination with octreotide. The skin of both her...

  • Clonixin.  // Reactions Weekly;3/22/2008, Issue 1194/1195, p14 

    This article describes the case of a 39-year-old man who developed anaphylaxis during an oral treatment with clonixin. An overview of the patient's medical history is provided. The results of the physical and laboratory tests undergone by the patient are discussed. His symptoms were solved after...

  • Iopamidol.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p29 

    The article presents a case study of a man who suffered from blood brain barrier dysfunction, toxic encephalopathy, aphasia and right hemiparesis while receiving iopamidol during left internal carotid angiography.

  • Iopromide.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p29 

    The article presents a case study of a 58-year-old man who developed transient cortical blindness secondary to iopromide administration during endovascular coiling of a right posterior inferior cerebellar artery aneurysm.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics